Compound 1128
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(Cc1ccccc1)C(C)=O
- IUPAC name:
4-[4-[acetyl(benzyl)amino]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide
- InChi:
InChI=1S/C39H46N6O6S2/c1-29(46)44(27-30-10-6-4-7-11-30)34-21-24-43(25-22-34)33-16-14-31(15-17-33)39(47)41-53(50,51)36-18-19-37(38(26-36)45(48)49)40-32(20-23-42(2)3)28-52-35-12-8-5-9-13-35/h4-19,26,32,34,40H,20-25,27-28H2,1-3H3,(H,41,47)/t32-/m1/s1
- InChiKey:
OYJUANGRJCOMLZ-JGCGQSQUSA-N
External links
![]() 42601681 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Haixiao Zhai, Xiong Cai, Curis, Inc.. . Bcl-2 inhibitors None. | 6 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 758.29 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 4.54 | |||
TPSA | 147.88 | |||
RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009036035 | 6 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.30 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5175 | Navitoclax | DB12340 | |
0.4591 | Sulfabenzamide | DB09355 | |
0.4450 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
0.4448 | Venetoclax | DB11581 | |
0.4365 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.4223 | Nelfinavir | DB00220 | |
0.4179 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4162 | (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide | DB03950 | |
0.4162 | (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide | DB02479 | |
0.4124 | Pipotiazine | DB01621 | |
0.4120 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.4099 | Repinotan | DB06506 | |
0.4036 | Saccharin | DB12418 | |
0.3981 | Amisulpride | DB06288 | |
0.3977 | Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide | DB03031 |